IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 18 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,359 | -6.9% | 2,382 | +50.6% | 0.00% | – |
| Q2 2023 | $4,683 | +57.5% | 1,582 | +182.0% | 0.00% | – |
| Q4 2022 | $2,973 | -81.4% | 561 | -86.2% | 0.00% | – |
| Q3 2022 | $16,000 | +128.6% | 4,061 | +118.2% | 0.00% | – |
| Q2 2022 | $7,000 | -61.1% | 1,861 | -46.3% | 0.00% | – |
| Q1 2022 | $18,000 | -87.3% | 3,466 | -84.8% | 0.00% | – |
| Q3 2021 | $142,000 | – | 22,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,058,035 | $2,931 | 0.15% |
| Gradient Capital Advisors, LLC | 26,808 | $74,258 | 0.03% |
| WEST PACES ADVISORS INC. | 1,665 | $4,612 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 28,652 | $79,366 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $48,430 | 0.00% |
| CITIGROUP INC | 7 | $19 | 0.00% |
| MORGAN STANLEY | 533 | $1,476 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 2,255 | $6,251 | 0.00% |
| WOLVERINE TRADING, LLC | 11,700 | $33 | 0.00% |